VitaSpring Biomedical Co. Ltd.
OTC: VSBC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ssu-Chuan Lai
- Employees
- 1
- Headquarters
- Irvine, United States
- IPO year
- 2019
- Market cap
- $2.3M
- Website
- https://www.vitaspringbio.com
Loading VSBC…
Loading profile data…Frequently asked questions about VSBC
What does VitaSpring Biomedical Co. Ltd. (VSBC) do?
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Where does VSBC trade?
VitaSpring Biomedical Co. Ltd. (VSBC) trades on the Other OTC.
What sector is VSBC in?
VitaSpring Biomedical Co. Ltd. (VSBC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of VitaSpring Biomedical Co. Ltd.?
Ssu-Chuan Lai is the chief executive officer of VitaSpring Biomedical Co. Ltd. (VSBC).
Where is VitaSpring Biomedical Co. Ltd. headquartered?
VitaSpring Biomedical Co. Ltd. is headquartered in United States.
Does VSBC pay a dividend?
VitaSpring Biomedical Co. Ltd. (VSBC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VSBC go public?
VitaSpring Biomedical Co. Ltd. (VSBC) completed its initial public offering in 2019.